Bioequivalence Study for the Safety and the Pharmacokinetics of DWC202313, DWC202314, and DWJ1622 in Healthy Volunteers Under Fed Condition.

Recruiting now · Phase 1

Conditions studied: Healthy Volunteers

In brief

This study aims to evaluate the safety and pharmacokinetic characteristics of DWJ1622, DWC202313, and DWC202314 in healthy adult volunteers under fed conditions.

Key facts

Study ID

NCT07267221

Run by

Daewoong Pharmaceutical Co. LTD.

People needed

36

Starts

2025-12-01

Expected to finish

2026-05-30

Last updated by the study team

2025-12-05

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Over 19 year old
• Healthy adult volunteers

You may not qualify if…

• with a history of mental disorder
• For female volunteers, those who are suspected of being pregnant or lactating

Where it is running

• H Plus YANGJI Hospital — Seoul, Gwanak-gu, South Korea (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.